½²«Tº_Áp¦X¶E©Òªº ¡q¯e¯f¶Eªvªº¼Ð·Ç¬yµ{¡r¤Þ¨¥
( §ó·s¤é´Á¡G2007-09-19 )
¡yÀYµhÂåÀY¡A¸}µhÂå¸}¡z¬O¤@¯ë¤H¹ï¤£¾ÇµL³Nªº»X¥j¤j¤Ò¨ã¦³ªº¦L¶H¡C¦ý¨Æ¹ê¤W¡A«o¥i¯à¥X²{¦b¤é¯q¤À¤uªº²{¤µ±M¬ìÂåÀøÅé¨î¤W¡C¬Ý¦Õ¦·ªºÂå®v¤£·|¬Ý¨{¤l¡F¬Ý¨{¤lªºÂå®v¤£·|¬Ý¤ßŦ¡F¬Ý¤ßŦªºÂå®v¤£·|¬Ý¸£³U¥Ê¡C¦ý¤@Ó¯gª¬©Î¯fµh¡A¥i¯à¦³¦UºØ¤£¦P¯f¦]¡F¦Ó¬YÓ¯f¦]ªí²{¥X¨Óªº¡A¤]¥i¯à¦³¤£¦Pªº¯gª¬©Î¯fµh¡C¨Ò¦p¤U¸¡³¡µh¡A¦³¥i¯à¬OG¸z¬ì¤Þ°_ªºG¸zª¢¡F¤]¦³¥i¯à¬Oªc§¿¬ì¤Þ°_ªº¿é§¿ºÞµ²¥Û¡F¤]¦³¥i¯à¬O°ü²£¬ì¤Þ°_ªº¤l®c¥~¥¥¡C¦]¦¹¦b¥xÆW³oºØ°ª«×ÂåÀø¤À¬ìªºÅé¨î¤U¡A§Ú̳̱`¬Ý¨ìªº¬O¡A¶m¿Ë¦]¬Y¤@¯fµh¨ì¥Ò±M¬ì¬Ýªù¶E¡A¸g¤@¨t¦CÀˬd³Q§iª¾¨S¯f¡A¤S¨ì¤A±M¬ì¬Ýªù¶E¡A¤]¸g¤@¨t¦CÀˬd¤]³Q§iª¾¨S¯f¡A¦³¥i¯à¤S¨ì¤þ±M¬ì¡B¤B±M¬ì¡A¬Æ¦Ü©ì¨ì¤õ¤sÃzµo¡A«æ©Êµo§@¡A³Q°e¨ì«æ¶E¡C¦]¦¹¡A¤@ÓºÙ¾ªº°ò¼h¶E©Ò¡AÀ³¦³¯à¤O§@¥ô¦ó¯gª¬ªº¦uªù¤H¡A¹ï©ó¥ô¦ó¶m¿Ëªº¯fµh¡A³£¯à§@¿ë§O¶EÂ_»PªvÀø¡A¯f±¡½ÆÂøªº¡A¤~Âà¶E¤jÂå°|¡C ¬°´£¤É¥»¶E©Ò¶Eªv¯e¯fªº¯à¤O¡A§ÚÌ¥é³ËÂå¾Ç¤¤¤ßªº§@ªk¡AÀ|¸Õ«Ø¥ß¾A¦X¥»¶E©Òªº¯e¯f¶Eªv¼Ð·Ç¬yµ{¡C¤Z¶m¿Ë¦]¬Y¤@½ÆÂø¯fµh¨Ó¥»¶E©Ò´N¶E®É¡A§ÚÌ·|¨Ì·Ó³o¤@¼Ð·Ç¬yµ{¶i¦æÀ³¦³ªº¶Eªv¨BÆJ¡A¹d²ÓÃû¿ò¡A±N¦UºØ¥i¯àªº¯f¦]³£¯à¦Ò¼{¨ì¡A¤£·|±¾¤@º|¸U¡A¶m¿Ë±NÀò±o³Ì¨ÎªºÂåÀø«~½è¡C
½Ð°Ñ¦Ò¤U±¦UºØ¯gª¬ªº¶Eªv¼Ð·Ç¬yµ{¡C§ÚÌ·|³°Äò¼W¥[·s¬yµ{»P×q¬J¦³¬yµ{¡A¨ÃÅwªï¦U±M¬ì¥ý¶i«e½ú¨Ó¨ç«ü±Ð¡ã
#¡m§Ü¥Òª¬¸¢ÃĪ«Carbimazoleªº¨Ï¥Î¬yµ{¡n (1)Carbimazol(10mg) 1#tid»P3#qd¦P®Ä¡C (2)90%¥H¤W¦³®Ä¡AYªvÀø¤TÓ¤ë«á¤´¨S®Ä¡A»Ý¼W¥[¾¯¶q¡C (3)¬ù»Ý5-6©P(1.5Ó¤ë)ªºªvÀø¡AT3,T4´N·|«ì´_¥¿±`¡A¦]¦¹¶}©lªvÀø«áªº1.5Ó¤ë ¡A§Y»Ý°lÂÜ¥Òª¬¸¢¥\¯à»PCBC/DC(¥Øªº¬OÀË´ú¦³§_¼È®É©Êªº¥Õ¦å²y°§C)¡C (4)T3,T4«ì´_¥¿±`«á¡ATSH¤´¥i¯à·|°¾§C¦n´X©P¦Ü´X¤ë¡C (5)YTSH°¾°ª¡A«hªí¥Ü¤w¦³Hypothyroidism¡A¦¹®É»Ý¥ß§Y°±Ãĩΰ§C¾¯¶q¡C (6)T3,T4«ì´_¥¿±`«á¡A§Ü¥Òª¬¸¢ÃÄ(Carbimazole10mg)¥i¥HºCºC°§C¾¯¶q¨ì1#qd¡C µM«á¨C1Ó¤ë´ú¥Òª¬¸¢¥\¯à¤@¦¸¡A¦@¤G¦¸¡Féw«á¡A¨C¤TÓ¤ë´ú¤@¦¸¡C (7)T3,T4«ì´_¥¿±`«á§Ü¥Òª¬¸¢ÃÄ¥i¦³¥H¤U¿ï¾Ü¡G (a)ºCºC°§C¾¯¶q (b)¤£°¾¯¶q¡A¦ý¥t¥[¥Òª¬¸¢¯À¤@»ô¨Ï¥Î¹F¤@¦~¡A¦A³æ¿W¨Ï¥Î¥Òª¬¸¢¯À3¦~¡A¥i ¥H¹w¨¾¥Òª¬¸¢¤®¶i´_µo¡C (8)¤@¯ë³Ì±`¨£ªºªvÀø´Á¶¡1-2¦~¡C (9)¬ù30-80%·|´_µo¡C©ö´_µoªº¼vÅT¦]¯À¬O¡G(a)¤jªº¥Òª¬¸¢¸~(b)¨Ï¥Î¤j¾¯¶qªº§Ü ¥Òª¬¸¢ÃĪ«¡A¤~¯à¨Ï¥Òª¬¸¢¯À¥\¯à«ì´_¥¿±`ªº±wªÌ¡C (10)Y¦³´_µo¡A¬ù75%¦b3Ӥ뤺·|´_µo¡A¬ù92%¦b¤G¦~¤º·|´_µo¡C (11)Carbimazole¡G¬ù¦³10%ªº¨Ï¥ÎªÌ¡A·|²£¥Í¼È®É©Êªº¥Õ¦å²y°§C (segment<1500/mm3)¡A¦¹®É¤£·|¦³¬Æ»ò¯gª¬¡F¬ù¦³0.3%ªº¨Ï¥ÎªÌ¡A·|²£¥ÍÁû²É ©Ê¥Õ¦å²y¯Ê¥F¯g(segment<500/mm3)¡A¦¹®É±`·|µo¿N¡B³ïÄVµh¡C¦]¦¹¡A¦b¨Ï¥Î
§Ü¥Òª¬¸¢ÃÄ1.5Ó¤ë«á¡A©Î¦³µo¿N³ïÄVµh®É¡A»Ý´úCBC/DC¡A¬Ý¬Ý¦³§_
segment<1500/mm3¡AY¦³¡A«h»Ý°±ÃÄ¡C«eªÌ¥u»ÝÆ[¹î¡F«áªÌ»Ý¥Î§Ü¥Í¯ÀªvÀø¡C
¤@¯ë2©P«á¡A¦å²y¼Æ§Y¥i«ì´_¥¿±`¡C
(12)¨Ï¥Î§Ü¥Òª¬¸¢ÃÄ¡AYµo¥Í»´·L°Æ§@¥Î¡A¥i¦Ò¼{´«¥t¤@ºØÃÄ¡A¦pCarbimazole´«
¦¨propylthiourcil¡F¦pªGµo¥ÍÄY«°Æ§@¥Î¡A«h²×¥Í¤£¦A¨Ï¥Î¦¹ÃþÃÄ¡C
¡¹¡m³J¥Õ§¿¶Eªvªº¼Ð·Ç¬yµ{¡n
Urine dipstick test >= 1+
1. ¦³§_ µo¿N¡Bªc§¿¹D·P¬V¡BªA¥ÎÃĪ«¡B¼@¯P¹B°Ê¡Burine sp.gr >1.02 ¡K¡K¡H
2. 1 week later¡Arecheck urine distick test¡AY¤´µM>= 1+¡A«h¦AÅç ACR¡A Cr (¦ýY²Ä¤@¦¸ªºurine distick test >= 2+ ¥iª½±µÅç ACR, Cr)
3.
(1) YACR<30mg/g¡G nothing worry
(2) YACR>30mg/g & < 300mg/g¡G
µû¦ô¦³§_systemic dz¡A¦pHTN¡BDM¡BSLE¡K¡H.
Y¦³systemic dz¡Atx it¡A¥B¶·¨C¹j¤»Ó¤ë°lÂܤ@¦¸ACR & Cr¡C
YµLsystemic dz¡A¶·¨C¹j¤TÓ¤ë°lÂܤ@¦¸ACR & Cr ¡FYACR «ùÄò¤W ¤É¦Ü>300mg/g¡Aµ¹pentoxifylline¡FYCr «ùÄò¤W¤É¡Aref. nephrologist for biopsy¡C
(3) YACR>300mg/g & < 1000mg/g¡Aµû¦ô¦³§_systemic dz¡H¦pHTN¡B DM¡BSLE¡K¡H.
Y¦³systemic dz¡A«htx it¡A¥B¶·¨C¹j¤»Ó¤ë°lÂܤ@¦¸¡AYACR «ùÄò¤W¤É¡A¦Ò¼{µ¹¤©pentoxifylline¡C
YµL systemic dz, «h»Ýµû¦ô¦³§_orthostatic proteinuria¡HYµLorthostatic proteinuria¡A¤]µLsystemic dz¡A«h¨C¤TÓ¤ëcheck ¤@¦¸ACR & Cr¡Aª½¨ìstable¡A¦A§ï¬°¥b¦~©Î¤@¦~f/u¤@¦¸¡AYACR «ùÄò¤W¤É¡A«hµ¹¤©§C¾¯¶qACEI/ARB©Îpentoxifylline¡CYCr«ùÄò¤W¤É¡A©ÎACR «ùÄò¤W¤É¨ì 2000mg/g¥H¤W¡A«href. nephrologist for biopsy¡C
(4) YACR>1000mg/g ¥B< 2000mg/g
Y¦³systemic dz¡A «htx it¡A¥B¶·¨Ö¥[pentoxifylline¡C
YµLsystemic dz¡A «hµ¹¤©§C¾¯¶qACEI/ARB ©Îpentoxifylline¡A¨C¤TÓ¤ë check ¤@¦¸ACR & Cr.¡Aª½¨ìstable¦A´î½wf/u ªº¦¸¼Æ¡FYCr«ùÄò¤W¤É©ÎACR «ùÄò¤W¤É¨ì2000mg/g¥H¤W¡A«href. nephrologist for biopsy¡C
¡¹¡m¦å§¿¶E§Mªº¼Ð·Ç¬yµ{¡n ¨S¦³ì¦]ªº¦å§¿(¤w±Æ°£¨}©Ê¦]¯À¡A¦p¤ë¸g¡B¿E¯P¹B¡B©Ê¦æ¬°¡B¯f¬r·P¬V¡B¨ü¶Ë ¡B§¿¸ô·P¬V¡BÃĪ«)¡A¥B¦³¥H¤U±¡§Î¡G (1) ¦³¦å§¿¡A¥B¦³·N¸qªº³J¥Õ§¿(µù)¡C (2) §¿²G¤ºªºRBCÅܧΩÎcast ¥X²{¡C (3) ¦³Cr. ªº²§±`¡C «hþÓ¤âÀˬd¦³§_µÇŦ¯fÅÜ(À\¦Ò¡m³J¥Õ§¿¶Eªvªº¼Ð·Ç¬yµ{¡n)¡A©ÎÂशµÇŦ¬ì( ¤×¨äÄÝ(2),(3)ªÌ)¡C ¦ýYµL¥H¤W¤TÏú±¡ªp¡A«hÀˬd¦³§_¨G§¿¬ì¯e¯f¡A¥i¥ý§@µÇŦ¶Wµªi©Îª½±µÂश
ªc§¿¬ì¡C
(µù) ©Ò¿×¡¨¦³·N¸qªº³J¥Õ§¿¡¨ ¬O«ü¡Adipstick test +1 ¥H¤W¡A¥B ACR>100mg/g¡A ©Î ¹j¥bÓ¤ëACR>50mg/g ¤G¦¸¡C
¡¹ ¡m¤ßµ±µh¶EÂ_¼Ð·Ç¬yµ{¡n Gr1.éw«¬¤ßµ±µh(stable angina)¡G¿E¯Pªº¹B°Ê¤~·|¯Ýµh¡A¥B³oºØ±¡úG¤w¶W¹L¤@ Ó¤ë¡C Gr2.¨ä¥L«DGr1ªÌªº¤ßµ±µh¡G¥]¬A¤£Ã©w«¬¤ßµ±µh(unstable angina)¡A©Î«æ©Ê¤ß ¦Ù±ð¶ë(acute myocardial infarction)¡C
¦bªù¶E®É¡A¤Z¬OÃhºÃ¥Ñ¤ß¦Ù¯Ê¦å¤Þ°_ªº¯Ýµh¡Aº¥ý°Ý¡§¥Ø«eªº¯Ýµh¬O§_¤´¦s¦b: (A) Y¬O¡A«hµ¹¤©¤f§tªü´µ¤ÇªL(aspirin)©Îµv»Ä¥Ìªo¡A¥ß§YÂà«æ¶E³B²z¡C (B) Y§_¡A«h¶·¦w±Æ¤ß¹q¹ÏÀˬd(EKG)¡CÀˬdµ²ªG¦³¤TºØ¥i¯à¡G (a) S-T ¬q¤U°©ÎT ªi¤ÏÂà¡Gµ¹¤f§taspirin©Îµv»Ä¥Ìªo¡A±¾«æ¶E¡C (b) S-T ¬q¤W¤É©Î·sªºBBB¡GY³Ìªñªº¯gª¬¤w¶W¹L24¤p®É¡A«hµ¹¤f§t aspirin¡A«Ø ij©ú¤Ñ±¾¤ßŦ¬ìªù¶E¡FY³Ìªñªº¯gª¬¥¼¶W¹L24¤p®É¡A«hµ¹¤f§taspirin¡A¥ß§Y ±¾«æ¶E¡C (c) ¤ß¹q¹Ï¥¿±`¡GYì¨Ó¯gª¬Äݤ£Ã©w©Ê¤ßµ±µhªÌ¡A¥ý©â¦å´úCPK(MB) ¡A µ¹ ¤fªAaspirin¡A©ú¤Ñ¦A¦^¨Ó¬Ý³ø§i¡A¤Î¦A§@EKG¡F©Î©ú¤Ñª½±µ±¾¤ßŦ¬ìªù¶E¡C Yì¨Ó¯gª¬ÄÝéw«¬¤ßµ±µhªÌ¡A«hµ¹¤fªAaspirin¡AÅñ¨ä¦³ ®É¶¡¦A¨ì¤ßŦ¬ìªù¶E¡A¥i¯à¶·§@¹B°Ê¤ß¹q¹Ï¡C ¦ýµL½×¦p¦ó¡A¨S¦³¥ß§Y±¾«æ¶EªÌ¡AY¦^®a«á¤Sµo¥Íunstable angina¡A³Ì¦n¥ß ¨è¨ì«æ¶E´NÂå¡C
¡¹¡m¤£³W«h¤ß¸õ¶Eªvªº¼Ð·Ç¬yµ{¡n Arrythemia with SVT and WPW syndrome ÄÝ©ó³oÓ»â°ìªº¯f±w¡A¤j³£»ÝÂà¶E¤jÂå°|³B²z¡A¦ý§Ṳ́]À³¤F¸Ñ¦b¤jÂå°|®É¡A¥i
¯àªº³B²z¨BÆJ¡A¹w¥ý§iª¾¯f±w¡F¦P®É§Ṳ́]n¦³¯à¤Oú¨©w¬O§_»Ý¥ß§Y±¾«æ¶E¡A©Î
§ï¤Ñ¦A±¾¤ßŦ¤º¬ìªù¶E¡A¥H§K¥²K¯f±wµL¿×ªºµJ¼{¡C
¡¹ÏA1,¹ÏA2
¡AfªººØÃþ:irregularly irregular heart beats (1) Af with rapid ventricular rate¡C(see¹ÏB) ¡E ±`¨£©óparoxysmal Af¡Bmitral valve disease¡A©Î hyperthyroidism¤Þ°_
ªºAf¡A©ö¤Þ°_ªÍ¤ô¸~¡B¤ß°IºÜ¡C ¡E ¥®ÉAfÀ³¥Hdiltiazen(or inderal) ±±¨î³t²v¡A¥²n®É¦A¥Hcardioversion
©Î¤fªAprocainamide and quinidine ¡AÁB¥¿¦¨³W«ßªºÄu©Ê¤ß«ß¡C ¡E Af±`¶·¤fªAaspirin¨Ó¹w¨¾°Ê¯ß®ê¶ë¡C ¡E¦ýY¥Ñwpw in Af (see¹ÏC)¤Þ°_ªºAf with rapid ventricular rate¡A¨ä¤ß
²v¥i¹F¨C¤À 280-300¤U¡A¦³wide bizarre QRS complex¹Ï§Î¡A»P¤@¯ëªºAf
±`¬Onarrow QRS¤£¦P¡A¦³¤Þ°_VF¤§¸·¡A³o®É³Ì¦n°µcardioversion ©ÎÀRª` procainamide µ¥ÃĪ«¡A¤£n¥Îb-blocker, diltiazen ©Îdigitalis¡C (2) Af with slow VR ¥i¨£Afªº¤ß«ß¨C¤ÀÄÁ20-30¤U¡A³o¼ËºCªºheart beats ¤Þ°_ªº¯gª¬¬°dizziness ¡Bdyspnea¡BCHF¡A¤Î¦³®Éfainting¡C³o¼ËªºEKG°£Af¥~¡A¤]¥i¯à¦³AV node ªº
¯fÅÜ¡A¬O¦w¸Ëpacemaker ªºindication¡C
(3) heart beats³W«h¤§Af ¥»¨Ó¦³Afªº¯f¤H¡A¬ðµMÅÜ¥¿±`¡A«h¦³¤TºØ¥i¯à¡G (a) AfÅܬ°¥¿±`ªºsinus rhythm(¥i¯àì¨Ó´NÄÝparoxysmal Af )¡C (b) Åܬ°complete AV block¡C (c) Åܬ°atrial flutter¡C ©Ò¥H¥ß¨è§@EKG¬O¥²¶·ªº¡A¥i¥HÀ°§U¶EÂ_¡C (4) paroxysmal Af (°}µo©ÊAf) ¡E ¤w¦³MS¡Bhyperthyroidism¡BCAD µ¥¯e¯f¡A¥»¨¤w®e©öµo¥ÍAfªºª¬ºA¡AY¥[
¤W¥¢¯v¡B³Ü©@°Ø¡Bmental & somatic stress µ¥¡A·|®e©ö»¤µo¡C°¸¦Ó¥¿±`¤H
¤]¥i¯àµo¥Í¡C ¡E ·s²£¥ÍªºAf¶·ª`·N¬O§_acute infarction ©ÒP¡C
¡Atrial flutter(AF) (see¹ÏD) ¡EAf ¦³®É¤]µo¥Í¦b¥¿±`¤ßŦ¡A¦ýAF »PAf¤£¦P¡AAF ¦hµo¥Í©ó¾¹©x©Ê¤ßÂïf¡A¦p CAD¡B¤ß¦ÙÅܩʵ¥¡A§e°}µo©Ê¸û¦h¡AYAF«ùÄò¤@©P¥H¤W±`Åܬ°Af¡C ¡EAF¥®ÉµL¶·¤fªAaspirinªº§Ü¾®¦å¾¯¡C ¡PSVT(paroxysmal supraventricular tachycardia) ¥i¤À¬°¡G 1. atrioventricular node reentrant tachycardia (AVNRT) 2. atrioventricular reentrant tachycardia (AVRT) §YWPW ¤Þ°_ªºPSVT 3. intraatrial reentrant tachycardia 4. sinus nodal reentry tachycardia
¡WPW syndrome(see¹ÏE)²£¥Íªº§Ö³t¤ß«ß±`¨£ªº¦³SVT(see¹ÏF) ¤Î Af¡C WPW syndrome with AVRTªºEKG«ÜÃø©M¨ä¥Lì¦]³y¦¨ªºPVST¬Û¿ëÃÑ(³£¬O¯¶
QRS)¡C¦ý¤@¥¹¸gadenosin iv dripªvÀø¡A§Ö³t¤ß¸õ¨ü±±¨î«á¥X²{ªºWPW
syndrome with preexcitationªºEKG¡A´N¯à³Q¤À¿ë¥X¦³§_WPW syndrome¡C
¡¹ÏG
¡RBBB (right bundle branch block) 1. RBBB ®É¤£·|ªýêAMIªºQS pattern ªí²{¡A¦ýLBBB·|¡A¥BRBBBªºST
elevation or depression ³£»PµL RBBB ªºªí²{¬Û¦P¡C 2. pure ªºRBBB (§YµL¦X¨Öischemia ±¡ªp¤U) , inverted T ·|¥ÑV1-V3³vº¥ÅÜ ²L¡A¨ì¤FV4 «á¡A§Y¤£¦Ainversion¡C¦ý¦b¦³ischemia ±¡ªp¤U¡A inverted T
·|¥ÑV1-V6³vº¥Åܲ`¡C 3. bifasicular block RBBB + ¹q¶b¥ª°¾ > RBBB + LA hemiblock RBBB + ¤£¥¿±`¹q¶b¥k°¾ > RBBB + LP hemiblock
¡LBBB YAMI «á¡A·sµo¥Í¤FLBBB³Q»{¬°¬Oµ¹thrombolytic ªºindication¡A¦]¦³sudden death ªº¦MÀI¡C
¡¹¡m³h¦åªº¶Eªv¼Ð·Ç¬yµ{¡n ¡EMicrocytic anemia STEP 1. ¥ý´úCBC/DC ¡÷ (1). Hb(¡õ), RBC(¡õ), MCV(¡õ) ¡÷¥i¯à IDA, chronic disease, sideroblastic anemia ¡÷STEP2 (2). Hb(¡õ), RBC(¡ô), MCV(¡õ¡õ), RDW(N) ¡÷ minor thallessemia STEP 2. ¦A´ú Fe, Ferritin, TIBC, RDW ¡÷ (1). Fe(¡õ): ¡nRDW(¡ô), Ferritin(¡õ),TIBC(¡ô),¡i(Fe/TIBC<5)¡j
¡÷IDA
¡nRDW(N), Ferritin(¡ô),TIBC(¡õ),¡iFe/TIBC=N(5-15)¡j
¡÷chronic disease (2). Fe(¡ô) ¥B¡iFe/TIBC > 45¡j¡÷ sideroblastic anemia
¡EMacrocytic anemia °Ýhistory taking, ¦³§_alcoholism, liver disease, jejunal & gastric resection, ¦Y¯Àµ¥.YµL, «href. ¦å²G¬ì¡C
¡ENormocytic anemia
º¥ý´úreticulocyte(Ret.)¡BBilibubin(t)¡BLDH.
¦AºâCRCÈ( Ret.¡ÑHCT/45)
Y(1) CRC¡Ö2
LDH¡ô¡Abilirubin(t)¡ô¡A«hªíhemolysis¡C
LDH¡Abilirubin(t) ¥¿±`¡A«hªíbleeding¡C
(2) CRC¡Ø2 ¡÷ YWBC¡BRBC ¬Ò¡õ¡A«h¥i¯à¦³pancytopenia¡C
YWBC¡BRBC¥¿±`¡A«h¥i¯à¦³chronic disease ©Î
renal failure¡C
¡· ©ó§Ú̶E©Òªºªù¶E¹ï©ó¯ÊÅK©Ê³h¦å¡A¥i´£¨Ñ¤fªAÅK¾¯ªvÀø¡A¨ä¤è¦¡¬°¡G
1. ¨C¤Ñ»Ý¸É¥R¬Û·í©ó¤¸¯ÀÅK(elementary iron)200~250mg¤§ÅK¾¯¡C
2. ¤À2~3¦¸©ó¶º«á°¨¤WªA¥Î¡A³q±`¥i¦P®ÉªA¥ÎVit C ¥H«P¶i¨ä§l¦¬¡A¦ý»ÝÁ×§K ¦P®ÉªA¥Î¨î»Ä¾¯(antacids)¡C
3. ¤fªAÅK¾¯¤@¯ë¬ù6~8¶g«á¡AHb¥i«ì´_¨ì¥¿±`¡A¦]¦¹¡AªvÀø¤@Ó¤ë«á¡AÀ³°lÂÜ HbÈ¡C
4. ¬°¤F¸É¨¬¶J¦sÅK(storage iron)¡AªvÀø®É¶¡»Ý3~6Ó¤ë¡C
¡¹¡m¤UIµh¡£lumbar pain¡¤¡n ¦³À£µhÂI¶Ü¡H ¨S¦³ ¡÷ ¸¡³¡µh¡H ¡÷ ¦³ ¡÷ radiation pain ¡û ¨S¦³ ¡÷ spine pain¡H¡÷ ¦³¡÷spinal problem ¡û ¨S¦³¡÷advanced evaluation ¦³ ¡÷À£µh¦blumbar spine ¡÷ HIVD À£µh¦b lumbar spine¨âÃä ¡÷ ¦b kidney ¡÷ renal problem ¡û ¦b¨ä¥¦¦a¤è ¡÷ ¦Ù½¤ª¢¡A¦Ù¦×©Ô¶Ë
¡¹¡m±aª¬¯p¯l¡n ±aª¬¯p¯l¤@¯ëªº¯fµ{¬O¥ý¦³¯«¸gµh¡A´X¤Ñ«á¤ô¯p·|±q³o¯«¸g¤ä°tªº¥Ö½§«_¥X¡A¦A¸g¤@¡B¤G©P¡A¤ô¯pºCºCµ²¯m®ø¥¢¡C¦ý¬Y¨Ç¤Hªº¯«¸gµh¥i¯à·|Ä~Äò¦s¦b¶W¹L¤@Ó¤ë¡A¬Æ¦Ü¼Æ¦~¡A³o®É´N³QºÙ¬°¡u±aª¬¯p¯l«á¯«¸gµh¡v¡A³oºØ¯kµh«D±`¹x©T¡A¤]¤£¦n³B²z¡C¦ý¤]¤£¬O¨CÓ±aª¬¯p¯l±wªÌ³Ì«á³£·|±o¨ì±aª¬¯p¯l«á¯«¸gµh¡A¦]¦¹±o¨ì±aª¬¯p¯l®É¡AÀ³ª§¨ú®É¶¡±µ¨ü³Ì¾A·íªº³B¸m¡C ¥H¤U¬O´XÓ»Ýn§â´¤ªºªvÀøì«h¡G (1) ¤fªA§Ü¯f¬rÃÄ(¦pacyclovir)»Ý¤Î¦ªA¥Î(³Ì¦n¦b¥X¤ô¯p«áªº¤T¤Ñ¤ºªA¥Î)¡A¤~¯àÁYµu¥Ö¯lµo§@¤Î«æ©Ê´Á¯kµhªº®É¶¡¡A¬Æ¦ÜÁÙ¥i´î¤Ö©MÁYµu±aª¬¯p¯l«á¯«¸gµhªºµo¥Í²v»Pµo§@®É¶¡¡C¦ý¤fªA§Ü¯f¬rÃĬO«Ü©ù¶QªºÃÄ¡AY¦Û¶O¤¤Ñ¥÷¬ù»Ý3000¤¸¡A¦]¦¹¹ï©ó¤Uz®e©ö²£¥Í¨Öµo¯g©Î±aª¬¯p¯l«á¯«¸gµhªº°ª¦MÀI¸s¡A«ØÄ³¤Î¦¨Ï¥Î§Ü¯f¬rÃÄ¡C³o¨Ç°ª¦MÀI¸s±wªÌ¥]¬A¡G(a)¶W¹L60·³¥H¤WªÌ(b)¯p¯lªø¦bÁy³¡¤Î¥Í´Þ¾¹©P³òªÌ(c)¤ô¯pº©©µ½d³ò«Ü¤jªÌ(d)«æ©Ê´Á¯kµh±¡§ÎÄY«ªÌ¡C¦ýY²Å¦X¥H¤U±ø¥ó¡A´N¥i¥Ó½Ð°·«O´X¥I¡A¶m¿ËÀ³¦n¦n§â´¤¡A±wªÌ¥]¬A¡G(a)µo¥Í¦bÁy³¡¤Î¥Í´Þ¾¹©P³òªº±aª¬¯p¯l¡A¥B¥X²{¤ô¯p¥¼¹F3¤Ñ(b)±aª¬¯p¯lµo¥Í¦b±µªñ²´·úªº³¡¦ì¡A¥i¯à¦M¤Î²´¨¤½¤ªÌ¡C (2)¦b¨Ï¥Î§Ü¯f¬rÃī᪺¤G¤Ñ«á¥i¥H¶}©l¨Ï¥Î¤fªAsteroids,¥Øªº¬O´î¤Ö¯f¨_°Ïªº¯kµh»P¥i¯à´î¤Ö±aª¬¯p¯l«á¯«¸gµhªºµo¥Í¡C¦ý¬O§_¾A¥Î©ó¨Ï¥Î§K¬Ì½Õ¸`¾¯©Î§K¬Ì¯à¤O¤£¥þªº±wªÌ¡A«h¯Ê¥F¤åÄmªºÃÒ©ú¡C¦ý¨Ï¥Îantibiotics©Msteroids¦X¨ÖªºÃÄ»I¶î©Ù¥~¥Î¡AÀ³³£¦³¤îµh®ø¸~ªº§@¥Î¡C (3) ¥Ñ©ó±aª¬¯p¯l«á¯«¸gµh©¹©¹µh¹F¼Æ¦~¡A¦]¦¹¹ï©ó¤Wz°ª¦MÀI¸sªº¥ô¤@±¡ªpªÌ¡A¦b¤ô¯pµ²¯m«á¤G©P¦Ü¤@Ӥ뤺¡A¥i«ØÄ³Âà¶E¤jÂå°|ªº³Â¾K¬ì©Î¯kµh¬ì¡A±µ¨ü¯«¸gªýÂ_ªvÀø¡A¥i¥H¹w¨¾º¸«á±aª¬¯p¯l«á¯«¸gµhªºµo¥Í¡C (4) ¹ï©ó¤w¦³±aª¬¯p¯l«á¯«¸gµh(§Y¯«¸gµh¶W¹L¤@Ó¤ëªÌ)ªº±wªÌ¡A²z·QªºªvÀøÃĪ«¬O§ÜÅöíwÃÄ(tegretol)©M§Ü¼~Æ{ÃÄ(TCA)¡C
¡¹¡m»e¸Á©ÎªêÀY¸Áîg¶Ë ªº³B¸m¬yµ{¡n 1.¤j©ó10°¦¸Á (1)¦³§_¥ß§Y©Ê¥ð§J¤ÏÀ³(30mins¤º)? ¦³-->«æ¶E. µL-->¶i¦æ(2). (2)ª`·N¬r©Ê¤ÏÀ³----²£¥Í¾î¯¾¦Ù·»¸Ñ¯g,µÇ°IºÜ,·»¦å(¦b¼Æ¤p®É¦Ü4¤Ñ¤ºµo¥Í). Y¦³-->«æ¶E. YµL-->¦^®aÆ[¹î¦³§_Áy¦â»a¥Õ,¯ù¦â§¿²G,¤ô¸~µ¥¯gª¬: Y¦³¯gª¬-->«h¥ß§Y¦^¶E©Î¦Ü«æ¶E. YµL¯gª¬-->medications for delayed anaphylactoid recation(¥i ¯à6hrs«áµo¥Í) with antihistamines, steroids, analgesic (ªAÃÄ1¤Ñ,Y¦³¥ý«eªº¸Áîg¶Ë°O¿ý,«h2¤Ñ);¥B 24hrs«á,¦^¶E´úCBC/DC, CR,CPK,U/Aµ¥. 2.¤p©ó10°¦¸Á ¦³§_¥ß§Y©Ê¥ð§J¤ÏÀ³(30mins¤º)? ¦³-->«æ¶E. µL-->medications for delayed anaphylactoid recation(¥i¯à6hrs«áµo¥Í) with antihistamines, steroids,analgesic (ªAÃÄ1¤Ñ,Y¦³¥ý«eªº¸Á îg¶Ë°O¿ý,«h2¤Ñ).
3.Y¦³§½³¡©Êªº¬õ¸~,»Ýª`·N¦³§_¨Öµo¸ÁºÛ²Õ´ª¢.
¡¹¡m ¨àµ£¦å§¿ªº¶EÂ_¼Ð·Ç¬yµ{¡n
¾Ç®Õ±`¦³§¿²G¿zÀ˪º°·¶E¡A¤pªB¤Í§¿²GY³QÀË´ú¥X¦³³J¥Õ§¿©Î¦å§¿¡A±`Åý®aªø¼~¼{¤£¤w¡C
«D±`¦hªº¯e¯f·|¤Þ°_³J¥Õ§¿©Î¦å§¿¡A³o¨Ç¯e¯f¦³ªº¥u»Ý°lÂÜÀˬd¡A¦³ªº«onµÇŦ¤Á¤ùÀˬd¤~¯à¤À¿ë¡A©Ò¥H¦p¦ó§Q¥Î³Ì²³æ§Ö³t¡A¥B¯à¥¨²ÓÃû¿òªº¤è¦¡¡A¨Ó©âµ·éõ¡A²`²`¦ÒÅç¨C¦ì²Ä¤@½uÂå®v¡C
¥»¶E©Ò¦³Å²©ó¦¹¡A¦]¦¹¾ã²z¥X¥H¤Uªº¶EÂ_¼Ð·Çµ{§Ç¡A¥H´£¤É§Ú̶E¯f¯à¤O¡AÅý³o¨Ç¤p¶m¿Ë¤£»Ý°Ê¤£°Ê¨ì¤jÂå°|¡A¤è«K¦Ó¹ê¥Î¡C
¤@Ó¥H¦å§¿¬°¥Dzªº¤pªB¤Í¡AÀ³¥ý°Ý¬O¦×²´¥i¨£ªº¦å§¿¡A©ÎÅã·LÃèÀˬd¤~µo²{ªº·L¶q¦å§¿-----
YÄÝ«eªÌª½±µ¶i¤J¥H¤Uµ{§Ç¡C
YÄÝ«áªÌ¡A«h¤@©P«á¦A«´ú¤@¦¸¡AY¤]¬O¦³·N¸qªº·L¶q¦å§¿¡A«h¶i¤J¥H¤Uµ{§Ç¡G
1. PAST HISTORY¡G³Ìªñ¦³§_UTI¡Atonsillitis¡AURIµ¥¡C
2. FAMILY HISTORY¡Ghereditary kidney disease¡Adeafness¡C
3. PHYSICAL EXAMINATION¡Gedema¡Ahypertension¡C
4. LABORATORY EXAMINATION¡G
a.U/A(for wbc, rbc, occult blood, crystal, proteinuria, cast)¡Cif proteinuria(+), then check ACR
b. Cr.
c. ASLO.
d. IgA (¶E©Ò¤£¯à°µ)
e. C3 (¶E©Ò¤£¯à°µ)
5. RENAL ECHO¡G
À˵ø¦³§_hydronephrosis¡Btumor¡Bstone¡Bcyst¡Bstructural abnormality¡C
6. ¨àµ£¦å§¿»Ý°µÅ²§O¶EÂ_ªº¯e¯f¥]¬A¡G
bladder lesion
transient hematuria
Ig A nephropathy
Idiopathic hematuria( family inheritance)
Alport syndrome
Idiopathic hypercalciuria
PSAGN
MPGN HUS(hemolytic uremic syndrome)
¡¹ °ü¤kªº¡mÀW§¿-§¿«æ¼xÔ¸s(frequency-urgency syndromes) ¡n
¦b§Ú̪º¶E©Òªù¶E®É¡A¹ï©ó¦³ÀW§¿-§¿«æ¯gª¬ªºªºªì¶E±wªÌ¡A§ÚÌ·|¨Ì¾Ú¯f¥v¡B§¿²GÀˬd¡B¤Î¶WµªiÀˬd¡A±N³oÃþ±wªÌ¤j²¤¥i¤À¬°¡G
1.¥¿±`ªº¦³®Ä»H¯Ö®e¶q¡G¤ô¥÷³Ü¤Ó¦h¡B±Æ¦½´î¤Ö¡B¦Y¤F§Q§¿ªºÃĪ«©Î¹ª«¡A¥]¬A©@°Ø¡C
2.¦³®Äªº»H¯Ö®e¶q´î¤Ö¡G¯f±w»H¯Ö®e¶q¥¿±`¡A¦ý±Æ§¿¶q«o¦b300ml¥H¤U¡C
3.µ²ºc©Ê»H¯Ö®e¶q´î¤Ö¡G¯f±w»H¯Ö®e¶q¤ñ¥¿±`¤Hªº»H¯Ö®e¶q´î¤Ö«Ü¦h¡A¦]¦Ó³y¦¨±Æ§¿¶q´î¤Ö¡C
4.º¡·¸«¬¡Bªý¶ë«¬¡C
5.§¿¸ô·P¬V¡A¥]¬Aatrophic urethritis¡C
¹ï©ó1¡A3¡A4¡A5¶µ¥unÁ{§É¶EÂ_¦¨¥ß§Y¥iµÛ¤âªvÀø¡A©ÎÂà¶E¦U¦³Ãö±M¬ì¡AªvÀø¤è¦¡¦U¦³¤£¦P¡C
¹ï©ó2¡A3¶µ«h¦³¥H¤U´XÓ¯e±w¶·§@Ų§O¶EÂ_¡G
urethral syndromes
sensory urgency
motor urgency
interstitial cystitis
¹ï©ó³o´XÓ¯e¯f¡AÁöµM¡«á¦U¦³¤£¦P¡A¦ýªvÀø¤è¦¡«o¤j¦P¤p²§¡A¦b§Ú̪ù¶E¥i¹Á¸Õ¥ýµ¹¤©¥H¤UªºªvÀø¡G
1.»H¯Ö°V½m
2.ÃĪ«ªvÀø
Anticholinergic agents
Anti-spasmodics
tricyclic antidepressant
H1 and H2 histamine blockers ( ¹ï©óinterstitial cystitis®ÄªG¸û¦n)
Y¤WzªºªvÀø®ÄªG¤£¨Î¡A¥i¯à»ÝnÂà¶E¦Ü¤jÂå°|°µ¶i¤@¨BªºÀˬd¡C
¡´B«¬»PC«¬¨xª¢±wªÌ¦b¥»¶E©Òªº¨Ò¦æ©Ê°lÂÜ
¦³B«¬¨xª¢»PC«¬¨xª¢ªº¶m¿Ë¡A¥i¦b¥»¶E©Ò§@ªø´Á©Êªº°lÂÜ¡A¥H¤Î¦¹w¨¾¨xµw¤Æªº§Î¦¨¡A©M¤Î¦µo²{¨x¸~½F¡C §Ú̪º¿ìªk¬O¡G
¨C¥b¦~°µ¨x¥\¯àÀˬd(GPT, GOT)¡Be§ÜìÀˬd¡B¨xÀù«ü¼ÆÀˬd¡B¤Î¨xŦ¶WµªiÀˬd¡C ¥þ³¡¶µ¥Ø¦b§Ú̶E©Ò³£¥i§¹¦¨¡A¦³°·«Oµ¹¥I¡A¦³»ÝnªÌ½Ð¦h§Q¥Î¡C
§Ú̪º¨ãÅé§@ªk¬O¡G
B«¬¨xª¢±wªÌ¡X
Ye§Üì¶§©Ê
a.GPT<80 ¥B >40 ¡÷ ¥ý¥HsilymarinªvÀø¡A¨C3Ó¤ë©â¦å°lÂܤ@¦¸¡C b.GPT>80 ¥B <200 ¡÷ ¥ý¥HsilymarinªvÀø3Ó¤ë«á¡A©â¦å°lÂÜ¡AY¤´µM GPT>80 ¡A«hÂà¶E¦Ü¤jÂå°|´úHBV-DNA¡A©Î¨xŦ²Õ´¤Á¤ùÀˬd¡A½T©wHBcAg¡A·Ç³Æ¬I¥H§Ü¯f¬rÃĪvÀø¡C
c.GPT>200 ¡÷ ¥ý¥HsilymarinªvÀø3Ó¤ë«á¡A©â¦å°lÂÜ¡AYGPT>200, ¥Be§Ü줴¶§©Ê¡A«hÂà¶E¦Ü¤jÂå°|¡A·Ç³Æ¬I¥H§Ü¯f¬rÃĪvÀø¡C
d.Y¶WµªiÀˬd¦³©úÅã¨xµw¤Æ ¡÷ «hÂà¶E¦Ü¤jÂå°|´úHBV-DNA¡A©Î¨xŦ²Õ´¤Á¤ù¯f²zÀˬd¡A·Ç³Æ¬I¥H§Ü¯f¬rÃĪvÀø¡C
Ye§Üì³±©Ê
a.GPT<80 ¡÷ ¥HsilymarinªvÀø¡A¨C3Ó¤ë©â¦å°lÂܤ@¦¸¡C b.GPT>80¡÷ ¥HsilymarinªvÀø¡A¨C3Ó¤ë©â¦å°lÂܤ@¦¸¡AY6Ó¤ë«á¤´µMGPT>80¡A«hÂà¶E¦Ü¤jÂå°|´úHBV-DNA¡A©Î¨xŦ²Õ´¤Á¤ùÀˬd¡A½T©wHBcAg¡A·Ç³Æ¬I¥H§Ü¯f¬rÃĪvÀø¡C
C«¬¨xª¢±wªÌ¡X
GPT>40 ¡÷ ¥HsilymarinªvÀø¡A¨C3Ó¤ë©â¦å°lÂܤ@¦¸¡AY6Ó¤ë«á¤´µMGPT>40¡A«hÂà¶E¦Ü¤jÂå°|¡A´úHCV RNA¡A©Î¨xŦ²Õ´¤Á¤ùÀˬd¡A·Ç³Æ¬I¥H§Ü¯f¬rÃĪvÀø¡C
|